Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
Portfolio Pulse from Lisa Levin
Several analyst forecasts were released on Friday, affecting the stocks of Accenture, Editas Medicine, NIKE, The Sherwin-Williams Company, Illumina, Restaurant Brands International, Femasys, CarMax, Flowserve Corporation, Domino's Pizza, and Trimble. The forecasts included price target changes and rating adjustments.
September 29, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stifel raised Editas Medicine's price target from $9 to $17 and upgraded the stock from Hold to Buy.
The raised price target and upgrade to Buy by Stifel indicates a positive outlook for Editas Medicine, which could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
JP Morgan boosted the price target for NIKE from $136 to $137, maintaining an Overweight rating.
The slight increase in price target by JP Morgan suggests a positive outlook for NIKE, which could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Berenberg increased the price target for The Sherwin-Williams Company from $224 to $249, maintaining a Hold rating.
The increase in price target by Berenberg suggests a positive outlook for The Sherwin-Williams Company, which could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
Piper Sandler cut the price target for Accenture from $312 to $300, maintaining a Neutral rating.
The cut in price target by Piper Sandler may create some uncertainty among investors, but the maintained Neutral rating suggests no major changes in the company's outlook.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Barclays lowered Illumina's price target from $150 to $100, maintaining an Underweight rating.
The lowered price target and maintained Underweight rating by Barclays suggests a negative outlook for Illumina, which could lead to a short-term decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100